TALEN

TALEN1-gsdf

ID
ZDB-TALEN-180227-1
Name
TALEN1-gsdf
Previous Names
None
Target
Target Sequence 1
5' - TCGTCCTGCTGCTGCTGGC - 3'
ZFIN BLAST NCBI BLAST Ensembl
Target Sequence 2
5' - TGACGGATGGAGCACAAAC - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
b1279 gsdf
b1280 gsdf
b1281 gsdf
Expression
Gene expression in Wild Types + TALEN1-gsdf
No data available
Phenotype
Phenotype resulting from TALEN1-gsdf
No data available
Phenotype of all Fish created by or utilizing TALEN1-gsdf
Phenotype Fish Conditions Figures
liver insb expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary amh expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
granulosa cell amh expression absent, abnormal gsdfb1279/b1279 standard conditions Fig. 5 with image from Yan et al., 2017
oocyte stage II increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 3,  Fig. 4 with image from Yan et al., 2017
testis fshr expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism liver vtg1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
liver lipid droplet increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 6 with image from Yan et al., 2017
ovary cyp19a1a expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
testis pcna expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
male organism testis increased size, abnormal gsdfb1279/b1279 standard conditions Fig. 4 with image from Yan et al., 2017
ovary fshr expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism liver ins expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
whole organism 11-oxotestosterone increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 8 from Yan et al., 2017
testis cyp11a1.1 expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism decreased fertility, abnormal gsdfb1279/b1279 standard conditions Fig. 3 from Yan et al., 2017
liver insrb expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary casp3a expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary hsd17b2 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary lhcgr expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary foxl2b expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
liver fabp10a expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary cyp11a1.1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism liver esr2a expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism liver pparg expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary ctnnb1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
testis inhbb expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary tp53 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
testis ddx4 expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 5 with image,  Fig. 7 from Yan et al., 2017
granulosa cell cyp19a1a expression absent, abnormal gsdfb1279/b1279 standard conditions Fig. 5 with image from Yan et al., 2017
testis casp3a expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
oocyte stage III decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 4 with image from Yan et al., 2017
ovary cyp17a2 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary nr0b1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism liver insra expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
whole organism increased mass, abnormal gsdfb1279/b1279 standard conditions Fig. 6 with image from Yan et al., 2017
unfertilized egg decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 3 from Yan et al., 2017
ovary hsd17b1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism brain hsd17b1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
Sertoli cell amh expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 5 with image from Yan et al., 2017
female organism liver esr1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary gata4 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
testis amh expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism liver fabp4a expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
oocyte stage IV absent, abnormal gsdfb1279/b1279 standard conditions Fig. 3,  Fig. 4 with image from Yan et al., 2017
ovary smad1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
oocyte stage I increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 3,  Fig. 4 with image from Yan et al., 2017
granulosa cell gata4 expression absent, abnormal gsdfb1279/b1279 standard conditions Fig. 5 with image from Yan et al., 2017
muscle lipid droplet increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 6 with image from Yan et al., 2017
testis tp53 expression increased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
ovary hsd17b3 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
oocyte maturation disrupted, abnormal gsdfb1279/b1279 standard conditions Fig. 4 with image from Yan et al., 2017
ovary cyp17a1 expression decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 7 from Yan et al., 2017
female organism estradiol decreased amount, abnormal gsdfb1279/b1279 standard conditions Fig. 8 from Yan et al., 2017
ovarian follicle stage II increased amount, abnormal gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
ovarian follicle stage III decreased amount, abnormal gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
testis increased size, abnormal gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
ovarian follicle stage I increased amount, abnormal gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
female organism decreased fertility, abnormal gsdfb1280/b1280 standard conditions Fig. 3 from Yan et al., 2017
female organism decreased fertility, abnormal gsdfb1281/b1281 standard conditions Fig. 3 from Yan et al., 2017
ovarian follicle stage II increased amount, abnormal amhb1375/b1375; gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
ovarian follicle stage III decreased amount, abnormal amhb1375/b1375; gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
testis increased size, abnormal amhb1375/b1375; gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
ovarian follicle stage I increased amount, abnormal amhb1375/b1375; gsdfb1279/b1279 (AB) standard conditions Fig. S1 from Yan et al., 2019
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.